B
Bull
Bull · 25%QLGN
$3.81
Scenario price
$3.210
+0.179 (+5.59%)At close
Loading chart…
- High
- 3.336
- Open
- 2.980
- VWAP
- 3.14
- Vol
- 373.84K
- Mkt Cap
- 1.12M
- Low
- 2.860
- Amount
- 1.17M
- EV/EBITDA, TTM
- 0.00
AIxCrypto Holdings, Inc., formerly Qualigen Therapeutics, Inc., is focused on building an ecosystem that integrates Artificial Intelligence (AI) and blockchain, bridging Web2 and Web3. This ecosystem unites a decentralized protocol, distributed network, AI DePIN and EAI RWA value regeneration, and a DeAI Agent product and technology platform designed to achieve optimal trading performance. Its core products include the BesTrade DeAI Agent and the AIxC ecosystem products. Its crypto business, CXC10, is centered on three growth engines which include six key products: C - Crypto 10 (C10) as Value Anchor, X - DeAI Agent, and C - RWA & Ecosystem Tokens. C - Crypto 10 (C10) as Value Anchor - through the C10 Digital Asset Treasury, C10 Index, and a potential C10 ETF. C - RWA & Ecosystem Tokens - including the C10 Stablecoin and the EAI + Crypto Dual-Bridge Real World Asset product, bridging traditional assets with Web3. It also develops and commercializes oncology and immunology therapies.
Valuation Metrics
The current forward P/E ratio for Aixcrypto Holdings Inc (QLGN) is -0.11, compared to its 5-year average forward P/E of -0.57.
Alphio AI Price Scenarios for QLGN
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
4.511-16Yahoo FinanceQualigen Therapeutics Shareholders Endorse All Proposals with Majority Vote; Company Set to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) After November 20 Nasdaq Ceremony and Reveals Shift to AI × Web3 Strategy
4.510-28NewsfilterQualigen Therapeutics to Change Name to AIxCrypto Following Stockholder Meeting on November 12, Outlining Three Key Objectives for 2025
2.010-24BenzingaIntel Shares Rise Approximately 8%; Check Out 20 Stocks Making Moves in Premarket Trading
7.510-24TipRanksWhat’s Behind the Surge in Qualigen Stock (QLGN) Today? Crypto Partnership Fuels the Increase
7.510-24BenzingaQualigen Therapeutics (QLGN) Shares Surge 62% in After-Hours Trading Following Collaboration with BitGo to Create Multi-Asset Crypto Treasury
QLGN FAQ — answered by Alphio AI
AIxCrypto Holdings, Inc., formerly Qualigen Therapeutics, Inc., is focused on building an ecosystem that integrates Artificial Intelligence (AI) and blockchain, bridging Web2 and Web3. This ecosystem unites a decentralized protocol, distributed network, AI DePIN and EAI RWA value regeneration, and a DeAI Agent product and technology platform designed to achieve optimal trading performance. Its core products include the BesTrade DeAI Agent and the AIxC ecosystem products. Its crypto business, CXC10, is centered on three growth engines which include six key products: C - Crypto 10 (C10) as Value Anchor, X - DeAI Agent, and C - RWA & Ecosystem Tokens. C - Crypto 10 (C10) as Value Anchor - through the C10 Digital Asset Treasury, C10 Index, and a potential C10 ETF. C - RWA & Ecosystem Tokens - including the C10 Stablecoin and the EAI + Crypto Dual-Bridge Real World Asset product, bridging traditional assets with Web3. It also develops and commercializes oncology and immunology therapies. It operates in the Technology sector (PHARMACEUTICAL PREPARATIONS industry).
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.